JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$1.09B |
| 2 |
Broadcom
AVGO
|
+$1.03B |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$970M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$877M |
| 5 |
Verizon
VZ
|
+$875M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.37B |
| 3 |
TWX
Time Warner Inc
TWX
|
+$764M |
| 4 |
IBM
IBM
|
+$737M |
| 5 |
Philip Morris
PM
|
+$640M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Financials | 14% |
| 3 | Technology | 12.71% |
| 4 | Healthcare | 9.7% |
| 5 | Consumer Discretionary | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
BRFS
2251
DELISTED
BRF SA
BRFS
| $7.79M | ﹤0.01% |
1,664,163
+1,035,649
| +165% | +$6.49M |
2013 Q2
20 quarters
|
|
2252
CALL
Thermo Fisher Scientific
TMO
$241B
| $7.75M | ﹤0.01% |
+37,400
| New | +$7.94M |
2018 Q2
0 quarters
|
|
2253
WisdomTree US MidCap Dividend Fund
DON
$3.78B
| $7.71M | ﹤0.01% |
215,440
-10,261
| -5% | -$360K |
2013 Q2
20 quarters
|
|
2254
CALL
McDonald's
MCD
$164B
| $7.71M | ﹤0.01% |
49,200
+29,700
| +152% | +$4.82M |
2018 Q1
1 quarter
|
|
2255
TriNet
TNET
$2.98B
| $7.71M | ﹤0.01% |
137,790
-75,168
| -35% | -$3.95M |
2014 Q2
16 quarters
|
|
|
2256
PUT
Thermo Fisher Scientific
TMO
$241B
| $7.71M | ﹤0.01% |
+37,200
| New | +$7.9M |
2018 Q2
0 quarters
|
|
|
MYOK
2257
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $7.7M | ﹤0.01% |
155,140
-19,155
| -11% | -$927K |
2016 Q1
9 quarters
|
|
2258
Tidewater
TDW
$4.09B
| $7.69M | ﹤0.01% |
265,789
+105,017
| +65% | +$3.29M |
2013 Q2
20 quarters
|
|
2259
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.25B
| $7.68M | ﹤0.01% |
55,795
+602
| +1% | +$78.8K |
2013 Q2
20 quarters
|
|
2260
Howard Hughes
HHH
$4.3B
| $7.68M | ﹤0.01% |
60,774
+42,086
| +225% | +$5.36M |
2015 Q4
10 quarters
|
|
|
MNTA
2261
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $7.68M | ﹤0.01% |
375,352
-308,931
| -45% | -$6.63M |
2015 Q1
13 quarters
|
|
2262
La-Z-Boy
LZB
$1.18B
| $7.67M | ﹤0.01% |
250,817
+153,638
| +158% | +$4.72M |
2013 Q2
20 quarters
|
|
2263
CALL
Zoetis
ZTS
$28.6B
| $7.67M | ﹤0.01% |
90,000
| – | – |
2017 Q1
5 quarters
|
|
|
2264
PUT
Zoetis
ZTS
$28.6B
| $7.67M | ﹤0.01% |
90,000
| – | – |
2017 Q4
2 quarters
|
|
2265
Nexa Resources
NEXA
$1.56B
| $7.65M | ﹤0.01% |
650,245
+9,322
| +1% | +$151K |
2017 Q4
2 quarters
|
|
|
BEL
2266
DELISTED
Belmond Ltd.
BEL
| $7.64M | ﹤0.01% |
685,299
-7,143
| -1% | -$81.6K |
2016 Q4
6 quarters
|
|
2267
HCI Group
HCI
$2.26B
| $7.63M | ﹤0.01% |
183,493
+88,417
| +93% | +$3.66M |
2013 Q3
19 quarters
|
|
2268
Cal-Maine
CALM
$3.08B
| $7.62M | ﹤0.01% |
166,187
+146,164
| +730% | +$7.06M |
2013 Q2
20 quarters
|
|
2269
Acadia Pharmaceuticals
ACAD
$3.43B
| $7.61M | ﹤0.01% |
498,339
-1,429,257
| -74% | -$25.5M |
2013 Q2
20 quarters
|
|
2270
Vanguard Morningstar Large-Cap ETF
VV
$54.1B
| $7.59M | ﹤0.01% |
60,835
+48,589
| +397% | +$6.04M |
2013 Q2
20 quarters
|
|
2271
PUT
Whirlpool
WHR
$1.99B
| $7.59M | ﹤0.01% |
51,900
-35,600
| -41% | -$5.41M |
2017 Q4
2 quarters
|
|
2272
Kelly Services Class A
KELYA
$571M
| $7.59M | ﹤0.01% |
337,992
-1,500
| -0.4% | -$39.1K |
2013 Q2
20 quarters
|
|
|
GDP
2273
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
| $7.55M | ﹤0.01% |
610,473
+1,424
| +0.2% | +$18.1K |
2017 Q2
4 quarters
|
|
|
DCPH
2274
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $7.52M | ﹤0.01% |
191,184
-96,578
| -34% | -$2.84M |
2017 Q4
2 quarters
|
|
2275
Vanguard Industrials ETF
VIS
$7.71B
| $7.52M | ﹤0.01% |
55,367
+1,192
| +2% | +$166K |
2015 Q4
10 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2018 Portfolio in Review
As of Q2 2018, JP Morgan Chase held 5,918 positions worth $486B, up 4.2% from $467B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2018 filing shows 539 new, 2,430 increased, 2,080 reduced and 346 closed positions. Its largest new stake was Evergy: 3,598,208 shares worth $202M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.58B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2018 buy was Evergy: 3,598,208 shares worth $202M.
- JP Morgan Chase added most to Salesforce in Q2 2018, an estimated $1.09B increase.
- JP Morgan Chase's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.58B.
- JP Morgan Chase fully exited Time Warner Inc in Q2 2018, selling an estimated $764M.
- JP Morgan Chase's ten largest holdings make up 17% of its $486B portfolio in Q2 2018.
- JP Morgan Chase opened 539 new positions and closed 346 in Q2 2018.
- JP Morgan Chase's portfolio value rose 4.2% quarter-over-quarter to $486B.
Based on JP Morgan Chase's 13F filing for Q2 2018, filed 14 Aug 2018.